ArticleJournal of experimental & clinical cancer research : CR2022

Wild-type IDH1 inhibition enhances chemotherapy response in melanoma.

Mehrdad Zarei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.